Axa S.A. Takes $5.41 Million Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

AXA S.A. acquired a new position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 285,035 shares of the medical instruments supplier's stock, valued at approximately $5,410,000. AXA S.A. owned approximately 0.14% of DENTSPLY SIRONA as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also bought and sold shares of the company. Riverview Trust Co bought a new stake in shares of DENTSPLY SIRONA in the fourth quarter worth approximately $26,000. MassMutual Private Wealth & Trust FSB grew its position in DENTSPLY SIRONA by 648.4% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier's stock worth $27,000 after purchasing an additional 1,232 shares during the period. UMB Bank n.a. raised its stake in DENTSPLY SIRONA by 60.8% during the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier's stock valued at $28,000 after buying an additional 564 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. lifted its holdings in shares of DENTSPLY SIRONA by 700.0% during the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier's stock valued at $33,000 after buying an additional 1,568 shares during the period. Finally, Quarry LP boosted its position in DENTSPLY SIRONA by 25.7% in the fourth quarter. Quarry LP now owns 3,816 shares of the medical instruments supplier's stock worth $72,000 after purchasing an additional 780 shares during the last quarter. Hedge funds and other institutional investors own 95.70% of the company's stock.

Wall Street Analysts Forecast Growth

XRAY has been the topic of several recent research reports. StockNews.com upgraded shares of DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a research note on Friday. Robert W. Baird decreased their price target on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating on the stock in a research report on Friday, February 28th. Piper Sandler cut their price objective on shares of DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating for the company in a research report on Wednesday, April 30th. Needham & Company LLC reaffirmed a "hold" rating on shares of DENTSPLY SIRONA in a report on Thursday, March 13th. Finally, Barrington Research boosted their price target on DENTSPLY SIRONA from $20.00 to $21.00 and gave the company an "outperform" rating in a report on Monday. Eleven analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to data from MarketBeat.com, DENTSPLY SIRONA presently has a consensus rating of "Hold" and an average target price of $20.36.

Insider Activity at DENTSPLY SIRONA

In other DENTSPLY SIRONA news, Director Gregory T. Lucier acquired 15,142 shares of the stock in a transaction on Monday, March 3rd. The stock was acquired at an average price of $16.51 per share, for a total transaction of $249,994.42. Following the completion of the transaction, the director now directly owns 81,971 shares of the company's stock, valued at $1,353,341.21. This trade represents a 22.66% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.50% of the stock is currently owned by insiders.

DENTSPLY SIRONA Price Performance

Shares of DENTSPLY SIRONA stock traded up $0.82 on Monday, hitting $16.63. 677,344 shares of the company traded hands, compared to its average volume of 2,950,690. DENTSPLY SIRONA Inc. has a 52 week low of $12.16 and a 52 week high of $28.69. The business has a 50-day simple moving average of $14.36 and a 200 day simple moving average of $17.54. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. The stock has a market capitalization of $3.31 billion, a P/E ratio of -8.04, a price-to-earnings-growth ratio of 1.80 and a beta of 0.92.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last released its quarterly earnings data on Thursday, May 8th. The medical instruments supplier reported $0.43 EPS for the quarter, beating the consensus estimate of $0.29 by $0.14. The business had revenue of $879.00 million during the quarter, compared to the consensus estimate of $854.75 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The business's revenue was down 7.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.42 EPS. Research analysts expect that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, April 11th. Stockholders of record on Friday, March 28th were given a dividend of $0.16 per share. The ex-dividend date was Friday, March 28th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 3.85%. DENTSPLY SIRONA's dividend payout ratio is currently -14.10%.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.